CRISPR Therapeutics AG — Investor Relations & Filings
CRISPR Therapeutics AG is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. The company leverages this technology to make precise, directed changes to genomic DNA. As a pioneer in the field, CRISPR Therapeutics has established a diverse portfolio of therapeutic programs across several disease areas, including hemoglobinopathies (such as sickle cell disease and beta-thalassemia), immuno-oncology, regenerative medicine, and cardiovascular disease. The company was one of the first to advance a CRISPR-based therapy into clinical trials and receive regulatory approval, aiming to create potentially curative treatments for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 4 SUBMISSION | 2017-06-01 | English | |
| FORM 3 SUBMISSION | 2017-06-01 | English | |
| FORM 4 SUBMISSION | 2017-05-19 | English | |
| 8-K | 2017-05-11 | English | |
| FORM 10-Q | 2017-05-11 | English | |
| FORM 4 SUBMISSION | 2017-05-09 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2017
15 filings
| |||||
| 12960089 | FORM 4 SUBMISSION | 2017-06-01 | English | ||
| 12960092 | FORM 3 SUBMISSION | 2017-06-01 | English | ||
| 12960091 | FORM 4 SUBMISSION | 2017-05-19 | English | ||
| 12960093 | 8-K | 2017-05-11 | English | ||
| 12960095 | FORM 10-Q | 2017-05-11 | English | ||
| 12960094 | FORM 4 SUBMISSION | 2017-05-09 | English | ||
| 12960096 | FORM 4 SUBMISSION | 2017-05-06 | English | ||
| 12960097 | FORM 4 SUBMISSION | 2017-05-04 | English | ||
| 12960099 | 8-K | 2017-05-04 | English | ||
| 12960098 | FORM 4 SUBMISSION | 2017-05-03 | English | ||
| 12960100 | FORM 4 SUBMISSION | 2017-04-29 | English | ||
| 12960101 | FORM 4 SUBMISSION | 2017-04-29 | English | ||
| 12960103 | 8-K | 2017-04-27 | English | ||
| 12960102 | FORM 4 SUBMISSION | 2017-04-26 | English | ||
| 12960104 | FORM 4 SUBMISSION | 2017-04-26 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for CRISPR Therapeutics AG, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CRISPR Therapeutics AG via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30936/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30936 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30936 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30936 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30936}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CRISPR Therapeutics AG (id: 30936)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.